Trial intelligence / Profile preview

STOP Study: Nicotine Replacement Therapy in Ontario Smokers

NCT00352781Phase 2Completed

Sponsor
Center for Addiction and Mental Health
Start
Jul 2006
Primary completion
Jan 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of nicotine in Tobacco Use Disorder (TUD), sponsored by Center for Addiction and Mental Health. Primary endpoint: Smoking Cessation. Started Jul 2006; status: completed.

02

Drugs

nicotine
03

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT00352781.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00352781.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call